EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Co‐treatment with erythropoietin derived HBSP and caspase‐3 siRNA : A promising approach to prevent fibrosis after acute kidney injury

Yuanyuan Wu iD, Yanan Wang, Fei Chen, Cheng Han, Lili Huang, Wenli Sai, Yaping Fan, Nigel J Brunskill, Bin Yang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Yuanyuan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical School, Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Fibrosis, Caspase 3, RNA, Small Interfering, Erythropoietin. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Department of Science and Technology, Postgraduate Research & Practice Innovation Program of Jiangsu Province: KYCX20_2804.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a risk factor of chronic kidney disease, without specific treatment. This study investigated the effect of co‐treatment using erythropoietin‐derived helix B surface peptide (HBSP) and caspase‐3 small interfering RNA (CASP3siRNA) on preventing fibrosis post AKI in order to achieve better efficacy by different action mechanisms. Ischemia–reperfusion (IR) in mice was induced by clamping bilateral renal pedicles for 30 min followed by 2‐week reperfusion, with HBSP and/or CASP3siRNA administered at the onset of IR. Serum creatinine, apoptosis, active caspase‐3 and high mobility group protein B1 (HMGB1) in kidneys were decreased by HBSP, CASP3siRNA or both, with increased PCNA. α‐SMA expression and collagen I deposition were also reduced by CASP3siRNA and both. Most interestingly, the co‐treatment further reduced tubulointerstitial damage and fibrosis, but raised PCNA compared to CASP3siRNA. EPOR/βcR was reduced by HBSP, and positively correlated with Sirius red staining, whereas EPOR was unchanged. In TCMK‐1 cells, H 2 O 2 raised apoptosis and α‐SMA were reduced by HBSP, while the same was occurred to HMGB1. However, HMGB1 was further increased by EPOR siRNA under H 2 O 2 stimulation with/without HBSP treatment. In conclusion, this study demonstrated synergistic long‐term renoprotection post IR‐AKI by HBSP and CASP3siRNA, which may be due to co‐inhibiting inflammation and stimulating repair at early stage, and subsequently preventing fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisCaspase 3RNA, Small InterferingErythropoietinAcute Kidney InjuryApoptosisAnimalsMiceMaleReperfusion InjuryMice, Inbred C57BLHMGB1 ProteinKidneyPeptide Fragments

Stichwörter der Autor:innen

acute kidney injurycaspase‐3helix B surface peptiderenal fibrosissiRNA

Substanzen

Caspase 3RNA, Small InterferingErythropoietinHMGB1 Proteinglutaminyl-glutamyl-glutaminyl-leucyl-glutamyl-arginyl-alanyl-leucyl-asparagyl-seryl-serinePeptide Fragments

Autor:innen und Institutionen

  • Department of Pathology, Medical School, Nantong University, Nantong, China.
  • Department of Nephrology, Leicester-Nantong Joint Institute of Kidney Science, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
  • Department of Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Cardiovascular Sciences, University of Leicester, University Hospitals of Leicester NHS Trust, Leicester, UK.

ORCID-Profile: Yuanyuan Wu, Bin Yang

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Department of Science and Technology
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province: KYCX20_2804

Zitieren

APA

Wu, Y., Wang, Y., Chen, F., Han, C., Huang, L., Sai, W., Fan, Y., Brunskill, N. J., & Yang, B. (2024). Co‐treatment with erythropoietin derived HBSP and caspase‐3 siRNA : A promising approach to prevent fibrosis after acute kidney injury. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70082

Vancouver

Wu Y, Wang Y, Chen F, Han C, Huang L, Sai W, et al. Co‐treatment with erythropoietin derived HBSP and caspase‐3 siRNA : A promising approach to prevent fibrosis after acute kidney injury. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70082

BibTeX
@article{Wu2024,
  author = {Wu, Yuanyuan and Wang, Yanan and Chen, Fei and Han, Cheng and Huang, Lili and Sai, Wenli and Fan, Yaping and Brunskill, Nigel J and Yang, Bin},
  title = {Co‐treatment with erythropoietin derived HBSP and caspase‐3 siRNA : A promising approach to prevent fibrosis after acute kidney injury},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70082}
}
Kostenlos starten →